Tomimatsu Misa

トミマツミサ | Tomimatsu Misa

Affiliation and department：
Job title： Research Associate

Research field (1)： Science education

Research theme for competitive and other funds (1)：

2015 - 2019 The establishment of new therapy targeting metabolic characteristics and cancer-stroma interaction for pancreatic cancer

Papers (8)：

Misa Yokoyama, Nobuhiro Tanuma, Rie Shibuya, Takeharu Shiroki, Makoto Abue, Kuniharu Yamamoto, Koh Miura, Kazunori Yamaguchi, Ikuro Sato, Keiichi Tamai, et al. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. International Journal of Oncology. 2018. 52. 3. 881-891
Takeharu Shiroki, Misa Yokoyama, Nobuhiro Tanuma, Ryuhei Maejima, Keiichi Tamai, Kazunori Yamaguchi, Tomoyuki Oikawa, Tetsuya Noguchi, Koh Miura, Tsuneaki Fujiya, et al. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism. CANCER SCIENCE. 2017. 108. 5. 931-940
Takeharu Shiroki, Misa Yokoyama, Nobuhiro Tanuma, Ryuhei Maejima, Keiichi Tamai, Kazunori Yamaguchi, Tomoyuki Oikawa, Tetsuya Noguchi, Koh Miura, Tsuneaki Fujiya, et al. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism. Cancer Science. 2017. 108. 5. 931-940
Ryuhei Maejima, Keiichi Tamai, Takeharu Shiroki, Misa Yokoyama, Rie Shibuya, Mao Nakamura, Kazunori Yamaguchi, Makoto Abue, Tomoyuki Oikawa, Tetsuya Noguchi, et al. Enhanced expression of semaphorin 3E is involved in the gastric cancer development. INTERNATIONAL JOURNAL OF ONCOLOGY. 2016. 49. 3. 887-894
Makoto Abue, Misa Yokoyama, Rie Shibuya, Keiichi Tamai, Kazunori Yamaguchi, Ikuro Sato, Nobuyuki Tanaka, Shin Hamada, Tooru Shimosegawa, Kazuo Sugamura, et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. INTERNATIONAL JOURNAL OF ONCOLOGY. 2015. 46. 2. 539-547

ｍore...

MISC (12)：

横山美沙, 渋谷莉恵, 坂本良美, 田沼延公, 望月麻衣, 中村真央, 玉井恵一, 山口壹範, 田中伸幸, 菅村和夫, et al. ピルビン酸キナーゼM2(PKM2)と膵癌細胞増殖. 膵臓. 2016. 31. 3. 547-547
横山美沙, 渋谷莉恵, 坂本良美, 田沼延公, 望月麻衣, 中村真央, 玉井恵一, 田中伸幸, 山口壹範, 菅村和夫, et al. ピルビン酸キナーゼM2(PKM2)と膵癌細胞増殖. 日本生化学会大会・日本分子生物学会年会合同大会講演要旨集. 2015. 88回・38回. [2P1096]-[2P1096]
Takeharu Shiroki, Misa Yokoyama, Ryuhei Maejima, Keiichi Tamai, Kazunori Yamaguchi, Tomoyuki Oikawa, Tetsuya Noguchi, Koh Miura, Tsuneaki Fujiya, Ikuro Sato, et al. PKM2 Is Dominantly Expressed in Normal Gastric Mucosa and Its Overexpression Is Involved in Gastric Cancer Development. GASTROENTEROLOGY. 2015. 148. 4. S563-S563
M. Abue, M. Yokoyama, R. Shibuya, K. Tamai, I. Sato, N. Tanaka, K. Yamaguch, S. Hamada, T. Shimosegawa, K. Sugamura, et al. The Evaluation of Circulating miR-483-3p and miR-21 in Plasma of Pancreatic Ductal Adenocarcinoma Patients. PANCREAS. 2014. 43. 8. 1340-1340
M. Yokoyama, R. Shibuya, T. Shiroki, N. Tanuma, K. Tamai, K. Yamaguchi, N. Tanaka, K. Sugamura, K. Satoh. Pyruvate Kinase Type M2 (PKM2) Is Selectively Expressed and Involved in Survival and Development in Pancreatic Ductal Adenocarcinoma Cells. PANCREAS. 2014. 43. 8. 1427-1428

ｍore...

Professional career (1)：

博士(医学) (東北大学)

Awards (2)：

2014/11 - Young Investigator Award ”Pyruvate kinase type M2 (PKM2) is selectively expressed and involved in survival and development in pancreatic ductal adenocarcinomacells”
2013/12 - 日本膵臓病研究財団平成25年度膵臓病研究奨励賞癌間質細胞で発現する Periostin を標的とした膵癌治療法の開発への基礎検討

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page